Literature DB >> 24751820

Increased risk of Parkinson's disease in patients with end-stage renal disease: a retrospective cohort study.

I-Kuan Wang1, Cheng-Li Lin, Yi-Ying Wu, Che-Yi Chou, Shih-Yi Lin, Jiung-Hsiun Liu, Tzung-Hai Yen, Chiu-Ching Huang, Fung-Chang Sung.   

Abstract

BACKGROUND: Studies on dyskinesia and Parkinson's syndrome associated with chronic kidney disease or end-stage renal disease (ESRD) have been mainly limited to case reports or case series studies. This population-based study investigated the risk of Parkinson's disease in patients with ESRD.
METHODS: From a universal insurance claims database of Taiwan, we established a cohort of 8,325 adults with newly diagnosed ESRD from 1997 to 2010 without a history of Parkinson's disease. A control cohort of 33,382 insured subjects without a history of kidney disease or Parkinson's disease was also selected, with frequency matched for age, sex and index date of the patients with ESRD. Both cohorts were followed up until the end of 2010.
RESULTS: The Parkinson's disease incidence was 1.55-fold higher in the cohort with ESRD than in the comparison cohort (48.8 vs. 31.7 per 10,000 person-years) with an adjusted hazard ratio of 1.73 (95% confidence interval, 1.39-2.15). Sex-specific and age-specific analysis showed a higher relative risk for women and younger patients with ESRD compared to the control cohort.
CONCLUSIONS: ESRD is significantly associated with an increased risk of Parkinson's disease. Close surveillance for Parkinson's disease should be considered for patients with ESRD.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 24751820     DOI: 10.1159/000358921

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  10 in total

1.  High exposure compared with standard exposure to metoclopramide associated with a higher risk of parkinsonism: a nationwide population-based cohort study.

Authors:  Shin-Chia Tsai; Shiow-Yunn Sheu; Li-Nien Chien; Hsin-Chien Lee; Eunice Jia-Shiow Yuan; Rey-Yue Yuan
Journal:  Br J Clin Pharmacol       Date:  2018-06-19       Impact factor: 4.335

Review 2.  Linking chronic kidney disease and Parkinson's disease: a literature review.

Authors:  Jesús D Meléndez-Flores; Ingrid Estrada-Bellmann
Journal:  Metab Brain Dis       Date:  2020-09-29       Impact factor: 3.584

3.  Incident Parkinson's disease in kidney transplantation recipients: a nationwide population-based cohort study in Korea.

Authors:  Seon Ha Baek; Sehoon Park; Mi-Yeon Yu; Ji Eun Kim; Sang Hyun Park; Kyungdo Han; Yong Chul Kim; Dong Ki Kim; Kwon Wook Joo; Yon Su Kim; Hajeong Lee
Journal:  Sci Rep       Date:  2021-05-18       Impact factor: 4.379

4.  Impact of Sjogren's syndrome on Parkinson's disease: A nationwide case-control study.

Authors:  Ming-Chi Wu; Xun Xu; Shan-Ming Chen; Yeu-Sheng Tyan; Jeng-Yuan Chiou; Yu-Hsun Wang; Li-Chi Lin; Chyong-Mei Chen; James Cheng-Chung Wei
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

Review 5.  Using Medical Claims Analyses to Understand Interventions for Parkinson Patients.

Authors:  Bastiaan R Bloem; Jan H L Ypinga; Allison Willis; Colleen G Canning; Roger A Barker; Marten Munneke; Nienke M De Vries
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

6.  Does nephrotic syndrome without chronic kidney disease increase the risk of Parkinson's disease and secondary parkinsonism? A nationwide population-based study in Taiwan.

Authors:  Tse-Yen Yang; Feng-Cheng Liu; Zheng-Hao Huang; Hsiang-Cheng Chen; Yu-Ching Chou; Cheng-Li Lin; Chia-Hung Kao; Hsin-Yi Lo
Journal:  BMJ Open       Date:  2018-07-07       Impact factor: 2.692

Review 7.  Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle?

Authors:  Sophie Liabeuf; Marion Pepin; Casper F M Franssen; Davide Viggiano; Sol Carriazo; Ron T Gansevoort; Loreto Gesualdo; Gaye Hafez; Jolanta Malyszko; Christopher Mayer; Dorothea Nitsch; Alberto Ortiz; Vesna Pešić; Andrzej Wiecek; Ziad A Massy
Journal:  Nephrol Dial Transplant       Date:  2021-12-28       Impact factor: 5.992

8.  Prognostic impact of polypharmacy by drug essentiality in patients on hemodialysis.

Authors:  Mineaki Kitamura; Kosei Yamaguchi; Yuki Ota; Satoko Notomi; Maya Komine; Rika Etoh; Takashi Harada; Satoshi Funakoshi; Hiroshi Mukae; Tomoya Nishino
Journal:  Sci Rep       Date:  2021-12-20       Impact factor: 4.379

9.  Transcranial sonography depicts a larger substantia nigra echogenic area in renal transplant patients on calcineurin inhibitors than on rapamycin.

Authors:  Nordeval Cavalcante Araújo; José Hermógenes Rocco Suassuna; Rita de Cássia Leite Fernandes
Journal:  BMC Nephrol       Date:  2022-03-17       Impact factor: 2.388

10.  Association Between Tuberculosis and Parkinson Disease: A Nationwide, Population-Based Cohort Study.

Authors:  Chih-Hao Shen; Chung-Hsing Chou; Feng-Cheng Liu; Te-Yu Lin; Wen-Yen Huang; Yu-Chiao Wang; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.